SMTL ID : 2hwf.5 (4 other biounits)

A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.80 Å

Oligo State

hetero-10-10-10-10-mer

Ligands

10 x JEN: 3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE(Non-covalent)

JEN.1: 9 residues within 4Å: Chain A: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.101, A:L.103, A:L.103, A:I.125, A:Y.147, A:I.220 JEN.2: 9 residues within 4Å: Chain E: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain E Hydrophobic interactions: E:I.101, E:L.103, E:L.103, E:I.125, E:Y.147, E:I.220 JEN.3: 9 residues within 4Å: Chain I: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain I Hydrophobic interactions: I:I.101, I:L.103, I:L.103, I:I.125, I:Y.147, I:I.220 JEN.4: 9 residues within 4Å: Chain M: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain M Hydrophobic interactions: M:I.101, M:L.103, M:L.103, M:I.125, M:Y.147, M:I.220 JEN.5: 9 residues within 4Å: Chain Q: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain Q Hydrophobic interactions: Q:I.101, Q:L.103, Q:L.103, Q:I.125, Q:Y.147, Q:I.220 JEN.6: 9 residues within 4Å: Chain U: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain U Hydrophobic interactions: U:I.101, U:L.103, U:L.103, U:I.125, U:Y.147, U:I.220 JEN.7: 9 residues within 4Å: Chain Y: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain Y Hydrophobic interactions: Y:I.101, Y:L.103, Y:L.103, Y:I.125, Y:Y.147, Y:I.220 JEN.8: 9 residues within 4Å: Chain 2: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain 2 Hydrophobic interactions: 2:I.101, 2:L.103, 2:L.103, 2:I.125, 2:Y.147, 2:I.220 JEN.9: 9 residues within 4Å: Chain 6: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain 6 Hydrophobic interactions: 6:I.101, 6:L.103, 6:L.103, 6:I.125, 6:Y.147, 6:I.220 JEN.10: 9 residues within 4Å: Chain a: I.101, L.103, I.125, Y.147, Y.193, N.215, M.217, I.220, H.241 6 PLIP interactions: 6 interactions with chain a Hydrophobic interactions: a:I.101, a:L.103, a:L.103, a:I.125, a:Y.147, a:I.220

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kim, K.H. et al., A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. J.Mol.Biol. (1993)

Release Date

1994-09-30

Peptides

HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP1): AEIMQUY26a
HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP2): BFJNRVZ37b
HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP3): CGKOSW048c
HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP4): DHLPTX159d

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
1

E
1

I
1

M
1

Q
1

U
1

Y
1

2
1

6
1

a
1

B
2

F
2

J
2

N
2

R
2

V
2

Z
2

3
2

7
2

b
2

C
3

G
3

K
3

O
3

S
3

W
3

0
3

4
3

8
3

c
3

D
4

H
4

L
4

P
4

T
4

X
4

1
4

5
4

9
4

d
4

HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP1)

HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP2)

HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP3)

HUMAN RHINOVIRUS 1A COAT PROTEIN (SUBUNIT VP4)

Related Entries With Identical Sequence